IntraBio Inc., a global biopharmaceutical company focused on developing and commercializing therapies for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has ...

Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, will announce data from the ongoing Phase 1/2 ...

A proud Cornishman who spent more than a decade delivering life saving blood across Cornwall has died peacefully at home with ...

The Department for Work and Pensions has confirmed a list of neurological conditions which qualify state pensioners for up to £496 a month. For the 2026/27 tax year, the maximum monthly payment for ...

More than 750,000 motorists across the UK have a medical condition that can affect their driving ability, according to recent ...

Drivers are being warned of hefty fines and prosecuted if they have medical conditions and fail to report them to the DVLA.

For people with a progressive genetic condition called Friedreich ataxia, which affects nerves and muscles, taking medicine for a year probably has little to no effect on measures of ataxia (problems ...

First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company's Pediatric Investigation Plan from the European Medicines Agency ...

First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s ...

SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 submitted to FDA in Q1 2026; Awaiting final FDA feedbackMultiple presentations ...

Tributes to a retired Northumbria Police Chief Inspector are among those being paid in The Chronicle deaths and funeral ...

A "cherished" father is among the lost loved ones commemorated in this week’s Leicester Mercury death notices. Keith ...